LSTA
7:00 AM
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders Lisata’s Board of Directors and management continues to evaluate strategic alternatives to enhance stockholder value In order to reduce operating expenses and
lisata.com